Firms

Cambridge Innovation Capital

Cambridge Innovation Capital

Cambridge Innovation Capital (CIC) is a Cambridge venture investment platform backing deep technology and life sciences, including artificial intelligence, quantum computing, photonics, semiconductors, robotics, genomics, gene therapy and neuroscience. It has a close relationship with the University of Cambridge and supports companies emerging from the regional research ecosystem. The website operator/parent Cambridge Innovation Capital Limited, company08243718, was incorporated October8,2012 and formerly used PLC; the distinct regulated subsidiary Cambridge Innovation Capital Manager Limited, company12002307, was incorporated May17,2019 and is FCA-authorised under FRN918898. This retained investor profile represents the published CIC investment platform, with legal parent and manager distinguished rather than treating every group entity as a cash subscriber. Its published team includes investment and operating staff, board directors, an advisory panel, specialist advisers, and current or explicitly former entrepreneurs in residence. FundII raised GBP225M in2022; its USD300M equivalent is not a second raise. The GBP100M Opportunity Fund was launched inFebruary2025 with primary-confirmed GBP20M British Patient Capital commitment and GBP15M Aviva investment; a final GBP100M cash close is not asserted. Legacy FundI emerged from corporate shareholder capital, with cumulative commitments and actual capital calls distinguished from a traditional external LP closing. AUM, portfolio co-investment and fund management transfers are not fresh closed cash. Existing institutional and individual investment records are preserved.

Founded
—
Type
Venture capital

Funds3

  • Cambridge Innovation Capital Fund I — legacy corporate investment pool—

    Legacy first investment pool funded by corporate shareholders, not asserted to be a conventional external LP fund. April2019 GBP150M new commitments took cumulative capital commitments to GBP275M; the latter is not a separate cash raise. OwnFY2020report identifies GBP42.5M capital calls and FY2019 GBP38.6M calls from that same financing. Structured total closedcash/day NULL because commitments and calls differ.

  • Cambridge Innovation Capital Fund II£225M

    OwnApril25,2022 announcement confirms raisedGBP225M oversubscribed FundII. USD300M is converted equivalent, not additionalcapital. Announcement date qualified; exact settlement day unpublishedNULL.

  • Cambridge Innovation Capital Opportunity Fund—

    LaunchedFebruary24,2025 at statedGBP100M size, not claimed as verifiedfinalcashclose. PrimaryLPs confirm actualGBP20M BritishPatientCapital commitment and GBP15M Aviva investment through its VentureGrowthLTAF; LTAFGBP150M is separatevehiclecapital. Structuredsize/dayNULL pending explicittotalclosedcash proof.

Team

$3M$600K – $6MCambridge, United Kingdom
$3M$600K – $6MCambridge, United Kingdom
$3M$600K – $6MCambridge, United Kingdom
$3M$600K – $6MCambridge, United Kingdom
$3M$600K – $6MCambridge, United Kingdom
$3M$600K – $6MCambridge, United Kingdom
$3M$600K – $6MParis, France
Rowan Chapman
Rowan Chapman

Cambridge Innovation Capital, Independent Non-executive Director

$0$0 – $0Menlo Park, California
$100K$10K – $500K
—— – —

Operations and support

Adam GlinsmanAdam GlinsmanAdvisory Panel Member
Andy NeelyAndy NeelyVice Chair
Andy RichardsAndy RichardsAdvisory Panel Member
Damian CrowtherDamian CrowtherEntrepreneur in Residence
Dipesh PatelDipesh PatelOperating Partner
Erik LangakerErik LangakerAdvisory Panel Member
Eva BelloEva BelloExecutive Assistant
Ferenc HuszárFerenc HuszárFormer Entrepreneur in Residence
Gregory WinterGregory WinterAdvisory Panel Member
Heiner DreismannHeiner DreismannAdvisory Panel Member
Humphrey BattcockHumphrey BattcockIndependent Non-executive Director
Ian JaunceyIan JaunceyOperating Partner
Ignas BudvytisIgnas BudvytisEntrepreneur in Residence
Ilana WisbyIlana WisbyEntrepreneur in Residence
James ChapmanJames ChapmanEntrepreneur in Residence
Jessica HallidayJessica HallidayStrategy Associate
John AstonJohn AstonNon-executive Director
John Lee (DisplayLink)John Lee (DisplayLink)Advisory Panel Member
Keith PetersKeith PetersAdvisory Panel Member
Kieran MurphyKieran MurphyAdvisory Panel Member
Laurent JespersLaurent JespersEntrepreneur in Residence
Mark LewisohnMark LewisohnAdvisory Panel Member
Martin FrostMartin FrostAdvisory Panel Member
Matt MaynardMatt MaynardEvents Manager
Michelle LamprechtMichelle LamprechtHead of Corporate Affairs
Mihriban TunaMihriban TunaFormer Entrepreneur in Residence
Neil LawrenceNeil LawrenceResident AI/ML Advisor
Nick RichardsNick RichardsGeneral Counsel and Company Secretary
Panos KakoullisPanos KakoullisIndependent Non-executive Director
Paul AnsonPaul AnsonOperating Partner
Philip WinterPhilip WinterEntrepreneur in Residence
Rebecca FitzgeraldRebecca FitzgeraldAdvisory Panel Member
Richard HallRichard HallAssociate
Rodrigo SantosRodrigo SantosEntrepreneur in Residence
Rojbin CutcuRojbin CutcuReceptionist and Office Administrator
Rupert BainesRupert BainesFormer Entrepreneur in Residence
Ruth AspelRuth AspelGroup Financial Controller
Sally EpsteinSally EpsteinEntrepreneur in Residence
Sam SturgeSam SturgeNon-executive Director
Steve LeonardSteve LeonardAdvisory Panel Member
Sylwia SzulcSylwia SzulcFinance Manager
Tabitha GoldstaubTabitha GoldstaubAdvisory Panel Member
Ted BriscoeTed BriscoeAdvisory Panel Member
Tim GarnettTim GarnettAdvisory Panel Member
Tom PageTom PageHead of Investor Relations
Victoria WoodwardVictoria WoodwardHead of Business Support

Co-investing

Investments